Candesartan Cilexetil/Hydrochlorothiazide Treatment in High-Risk Patients with Type 2 Diabetes Mellitus and Microalbuminuria

  • The CHILI T2D Study
  • Reinhard Ketelhut, Peter Bramlage
  • Clinical Drug Investigation, May 2010, Springer Science + Business Media
  • DOI: 10.1007/bf03256905

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

The following have contributed to this page: Peter Bramlage